Loading market dashboard
Senzime AB (publ)
SNZZFHealthcareOTCSE
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
UPPSALA, SE / ACCESS Newswire / June 5, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the launch of TetraAnalytics™, a new data analytics platform designed to expand the value of the TetraGraph® system. TetraAnalytics generates advanced clinical and operational insights, helping hospitals align with clinical guidelines, increase utilization and further leverage the benefits of quantitative neuromuscular monitoring.
UPPSALA, SE / ACCESS Newswire / June 3, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) announced today advancements within pediatric anesthesia, securing another top ranked pediatric hospital contract. The pediatric hospital, based in the Eastern U.S., awarded the contract to Senzime to equip all operating rooms with TetraGraph systems following a competitive evaluation.
UPPSALA, SE / ACCESS Newswire / June 1, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced the launch of its latest TetraSens® EMG sensor for use with the TetraGraph® Train-of-Four monitoring system. The new sensor is designed and manufactured with focus on sustainability, performance and usability.
UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II 510(k) clearance. The new FDA clearance follows submission in April 2026 and expands the system's capabilities, further strengthening the TetraGraph's competitive advantages.
UPPSALA, SE / ACCESS Newswire / May 19, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at the Company's premises on Verkstadsgatan 8, Uppsala, whereby the shareholders primarily resolved on the following matters.
UPPSALA, SE / ACCESS Newswire / April 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced new appointments to its Global Executive Leadership Team, including the recruitment of a new Vice President of U.S. Sales and the appointment of a Vice President of Clinical and Medical Affairs. Josi Wood, MBA, has been recruited to strengthen the company's U.S. commercial operations as Vice President of U.S. Sales, assuming a newly created leadership role within Senzime.
Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call Transcript
Senzime AB (publ) (SNZZF) Q1 2026 Earnings Call Prepared Remarks Transcript
UPPSALA, SE / ACCESS Newswire / April 22, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is now available on the company's website www.senzime.com. Financial information January - March 2026 Net sales amounted to SEK 23,233 thousand (23,499), a decrease of 1% Currency-adjusted net sales increased by 11% Sales in US market amounted to SEK 14,805 thousand (15,551), a decrease of 5% Sales in other markets amounted to SEK 8,427 thousand (7,949), an increase of 6% Gross margin before depreciation amounted to 63.1% (65.9) Operating expenses amounted to SEK 35,562 thousand (37,297) Operating profit before depreciation amounted to SEK -20,202 thousand (-20,838).
UPPSALA, SE / ACCESS Newswire / April 20, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has expanded its agreements with a leading hospital system (IDN) with network in the southeastern US. With today's expansion contract for additional 65 TetraGraph-systems, the network will have over 160 TetraGraph's installed, generating an estimated annual recurring revenue exceeding SEK 6 million for Senzime.
UPPSALA, SE / ACCESS Newswire / April 17, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general meeting on Tuesday 19 May 2026 at 16.00 at the Company's premises on Verkstadsgatan 8, house 1, Uppsala.
UPPSALA, SE / ACCESS Newswire / April 17, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to presentations of the first quarter report for 2026 on April 22. The report will be published at 08.00 am CEST the same day.
UPPSALA, SE / ACCESS Newswire / April 9, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has secured strategic contracts to supply hospitals within one of the world's largest integrated healthcare networks (IDN), encompassing a potential of more than 150 hospitals across the United States. The initial phase includes deliveries of TetraGraph systems to a first group of hospitals within the network, marking the beginning of what has the potential to become Senzime's largest system-wide agreement in the US to date.
